March 2025 Archive: New Alzheimer Options and Ethambutol Eye Risks

If you stopped by MyGenericPharmacy in March, you probably saw two hot topics: fresh alternatives to Aducanumab for Alzheimer's and a warning about ethambutol causing optic neuritis. Both pieces give practical tips you can use right away.

Top Alzheimer Treatment Alternatives

The first article broke down seven options that could replace Aducanumab this year. It started with Omega‑3 supplements, which many people already take for heart health. The piece explained how EPA and DHA may help brain cells stay flexible, but also reminded readers that the evidence is still growing.

Next up were anti‑inflammatory drugs like low‑dose ibuprofen. The writer pointed out that some trials show reduced plaque buildup, yet warned about stomach issues if you skip a doctor’s check. Then came lifestyle hacks: regular exercise, a Mediterranean diet, and quality sleep. Those aren’t new ideas, but the article gave specific actions—like 30 minutes of brisk walking three times a week or swapping butter for olive oil.

Three newer therapies also got attention: a monoclonal antibody called lecanemab, a gene‑editing approach still in early trials, and a combination of BACE inhibitors with cognitive training apps. For each, the article listed one clear pro (e.g., faster plaque clearance) and one drawback (e.g., high cost or limited availability).

Finally, the guide reminded you to talk to your neurologist before mixing any supplement or drug. The takeaway? You have several paths to support memory, but each needs a personalized plan.

What You Should Know About Ethambutol and Vision

The second post tackled ethambutol, a common TB medicine, and its link to optic neuritis—a painful inflammation of the optic nerve that can blur vision. It started with a simple question: “Ever notice your colors looking dull after a few weeks on TB meds?” That’s often the first sign.

According to the article, about 1‑2% of patients on ethambutol develop this issue, usually within 2‑4 months of treatment. Early symptoms include trouble distinguishing red from green and reduced sharpness at night. If you spot these signs, stop reading and call your doctor right away.

The piece gave three practical steps to protect your eyes: schedule a baseline eye exam before starting ethambutol, get follow‑up checks every month, and report any vision change immediately. It also mentioned that lowering the dose can reduce risk, but only a physician should adjust medication.

Wrapping up, the article emphasized that while ethambutol saves lives by fighting TB, staying alert to eye health can prevent permanent damage. A quick check‑in with your eye doctor could make all the difference.

Both March posts aim to empower you with clear actions—whether you’re hunting for new Alzheimer treatments or monitoring a TB drug’s side effects. Keep these tips handy and stay proactive about your health.